AbbVie Inc. is 68.8x more valuable than Liquidia Corp by market capitalization ($399.47 B vs $5.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LQDA | ABBV |
|---|---|---|
| Market cap | $5.80 B | $399.47 B |
| US-listed rank | #1290 | #28 |
| Revenue (latest FY) | $158.32M | $61.16B |
| Net income (latest FY) | -$68.92M | $4.23B |
| Net margin | -43.5% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 628 | 1,008 |
AbbVie Inc. is 68.8x more valuable than Liquidia Corp by market capitalization ($399.47 B vs $5.80 B).
In their latest fiscal years, Liquidia Corp reported $158.32M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Liquidia Corp and AbbVie Inc., or browse the full rankings.